PharmacyCodes



Alpha-Methyldopahydrazine en es it fr

Categoria

Alpha-Methyldopahydrazine Nombres de marca, Alpha-Methyldopahydrazine Analogos

Alpha-Methyldopahydrazine Marca los nombres de mezcla

  • Atamet (carbidopa + levodopa)
  • Sinemet (carbidopa + levodopa)

    • Alpha-Methyldopahydrazine Formula quimica

    C10H14N2O4

    Alpha-Methyldopahydrazine RX enlace

    http://www.rxlist.com/cgi/generic/sinemet.htm

    Alpha-Methyldopahydrazine FDA hoja

    Alpha-Methyldopahydrazine MSDS (hoja de seguridad de materiales)

    Alpha-Methyldopahydrazine Sintesis de referencia

    Chemerda et al., Patente de EE.UU.. 3,462,536 (1963)

    Alpha-Methyldopahydrazine Peso molecular

    226.229 g/mol

    Alpha-Methyldopahydrazine Punto de fusion

    203-205oC

    Alpha-Methyldopahydrazine H2O Solubilidad

    3,8 mg / L

    Alpha-Methyldopahydrazine Estado

    Solid

    Alpha-Methyldopahydrazine LogP

    0.494

    Alpha-Methyldopahydrazine Formas de dosificacion

    Comprimido (25 mg)

    Alpha-Methyldopahydrazine Indicacion

    Para el tratamiento de los síntomas de la enfermedad de Parkinson idiopática (parálisis agitante), parkinsonismo postencefalítico

    Alpha-Methyldopahydrazine Farmacologia

    Carbidopa, un inhibidor de la descarboxilasa no competitivo, se utiliza en combinación con levodopa para el tratamiento de la enfermedad de Parkinson.

    Alpha-Methyldopahydrazine Absorcion

    Descarboxila rápidamente en dopamina en los tejidos extracerebrales de modo que sólo una pequeña parte de la dosis administrada es transportado sin cambios en el sistema nervioso central.

    Alpha-Methyldopahydrazine Toxicidad

    Los síntomas de una toxicidad carbidopa incluyen espasmos musculares o debilidad, espasmos de los párpados, náuseas, vómitos, diarrea, un latido irregular del corazón, confusión, agitación, alucinaciones y pérdida del conocimiento.

    Alpha-Methyldopahydrazine Informacion de Pacientes

    Carbidopa is used with levodopa to treat Parkinson's disease. Parkinson's disease
    is believed to be related to low levels of a chemical called dopamine (DOE pa meen)
    in the brain. Levodopa (Dopar, Larodopa) is turned into dopamine in the body.
    Carbidopa is used with levodopa to prevent the breakdown (metabolism) of levodopa
    before it can reach the brain and take effect. Carbidopa is only effective if it is
    taken with levodopa. It has no effect if it is used alone. Carbidopa is used with
    levodopa to treat the stiffness, tremors, spasms, and poor muscle control of
    Parkinson's disease. These medications are also used to treat the same muscular
    conditions when they are caused by drugs such as chlorpromazine (Thorazine),
    fluphenazine (Prolixin), perphenazine (Trilafon), and others.

    Alpha-Methyldopahydrazine Organismos afectados

    Humanos y otros mamíferos